The New Jersey Economic Development Authority has recently announced Sunnylife Pharma Inc. is its newest tenant at its life sciences incubator Commercialization Center for Innovative Technologies in North Brunswick.
Sunnylife Pharma is a contracted research services organization focused on the unmet needs of patients. It also helps drug-discovery companies reduce research and development costs by assisting with research.
CCIT is a 46,000-square-foot biotech incubator in a 50-acre research park. Labs range from 800 to 1,000 square feet and tenants have the opportunity to share conference rooms, offices, support staff, small business development resources, reception services, kitchens, loading docks and more.
“Creating a culture of innovation is a centerpiece of Gov. Murphy’s vision for a stronger and fairer economy, and nurturing emerging companies like Sunnylife Pharma is central to executing on that vision,” EDA CEO Tim Sullivan said. “Removing barriers to commercialization and profitability for entrepreneurs with novel ideas will pave the way to strengthen economic opportunity in this high growth sector.”
CCIT’s collaborative areas will allow Sunnylife Pharma to network with members of other drug-discovery companies currently at the incubator, including Aucta Pharmaceuticals, Quixgen, and Grace Therapeutics, as well as research organization like Kamat Pharmatech and API Pharma Tech.
“I discovered CCIT based on recommendations from several former colleagues and found the staff to be very welcoming and the facilities well-suited to our needs,” Sunnylife co-founder and CEO Xibin Liao said. “Furthermore, we find many advantages in CCIT’s location near major cities, universities and pharmaceutical companies.”